Immunotherapy for Infectious Diseases

Dendritic Cells 111
19. Holland SM, Eisenstein EM, Kuhns DB, Turner ML, Strober WA, Gallin JI. Treatment of
refractory disseminated nontuberculous mycobacterial infection with interferon �: a preliminary
report. N Engl J Med 1994; 330:1348.
20. Dupuis M, Peshwa MV, Benike C, et al. Allogeneic dendritic cell induction of HIV specific
cytotoxic T lymphocyte responses from T cells of HIV-1 infected and uninfected
individuals. AIDS Res Hum Retroviruses 1997; 13:33–39.
21. Macatonia SE, Taylor PM, Knight SC, Askonas BA. Primary stimulation by dendritic cells
induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med 1989;
169:1255–1264.
22. Kast WM, Boog CJ, Roep BO, Voorduow AC, Melief CJ. Failure or success in the restoration
of virus-specific cytotoxic T lymphocte response defects by dendritic cells. J Immunol
1988; 140:3186–3193.
23. Nonacs R, Humborg C, Tam JP, Steinman RM. Mechanisms of mouse spleen dendritic
cell function in the generation of influenza-specific, cytolytic T lymphocytes. J Exp Med
1992; 176:519–529.
24. Mehta-Damani A, Markowicz S, Engleman EG. Generation of antigen-specific CD4�
T cell lines from naïve precursors. Eur J Immunol 1995; 25:1206–1211.
25. Mehta-Damani A, Markowicz S, Engleman EG. Generation of antigen-specific CD8�
CTLs from naïve precursors. J Immunol 1994; 153:996–1003.
26. Huscein LA, Lehner T. Comparative investigation of Langerhans’ cells and potential
receptors for HIV in oral genitourinary and rectal epithelia. Immunology 1995;
85:474–484.
27. Rowland-Jones SL. HIV: The deadly passenger in dendritic cells. Curr Biol 1999;
9:R248–R250.
28. Patterson S, Gross J, Bedford P, Knight SC. Morphology and phenotype of dendritic cells
from peripheral blood and their productive and non-productive infection with human
immunodeficiency virus type 1. Immunology 1991; 101:672–680.
29. Weissman D, Li Y, Ananworanich J, et al. Three populations of cells with dendritic morphology
exist in peripheral blood, only one of which is infectable with human immunodeficiency
virus type 1. Proc Natl Acad Sci USA 1995; 92:826–830.
30. Patterson S, Knight SC. Susceptibility of human peripheral blood dendritic cells to infection
by human immunodeficiency virus. J Gen Virol 1987; 68:1177–1181.
31. Cameron PU, Forsum U, Teppler H, Granelli-Piperno A, Steinman RM. During HIV-1
infection most blood dendritic cells are not productively infected and can function normally
in clonal expansion of CD4� T cells. Clin Exp Immunol 1992; 88:226–236.
32. Patterson S, Robinson SP, English NR, Knight SC. Subpopulations of peripheral blood
dendritic cells show differential susceptibility to infection with a lymphotropic strain of
HIV-1. Immunol Lett 1999; 66:111–116.
33. Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, Lanier LL, and
Liu YJ. Distinct cytokine profiles of neonatal natural killer T cells after expansion with
subsets of dendritic cells. J Exp Med 2001; 193(10):1221–1226.
34. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, and Colonna
M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts
of Type I interferon. Nat Med 1999; 5(8):919–923.
35. Knight SC. Infection of dendritic cells with HIV-1. AIDS Res Hum Retroviruses 1994;
10:1591–1595.
36. Vyarkanam A, Matear PM, Cranenburg C, et al. T cell responses to peptides covering the gag
p24 region of HIV-1 occur in HIV-1 seronegative individuals. Int Immunol 1991; 3:939–947.
37. Takahashi H, Nakagawa Y, Yokomuro K, Berzofsky JA. Induction of CD8� cytotoxic T
lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptidepulsed
dendritic cells. Int Immunol 1993; 5:849–857.
38. Tschachler R, Groh W, Popovic M, et al. Epidermal Langerhans cells: a target for HTLV-